SCHEMBL178661

SCHEMBL178661

COc1ccc(-c2nc(C)c3[nH]c4cc(OC)ccc4c3n2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.67
DYRK1A Q13627 7/20 0.58
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 4/20 0.51
HPGD P15428 3/20 0.51
ACHE P22303 2/20 0.51
DYRK3 O43781 1/20 0.51
CCNT1 O60563 1/20 0.51
CCNB2 O95067 1/20 0.51
CYP1A2 P05177 1/20 0.51
CDK1 P06493 1/20 0.51
CYP3A4 P08684 1/20 0.51
ADRA2A P08913 1/20 0.51
CYP2D6 P10635 1/20 0.51
CCNB1 P14635 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51
CCNA2 P20248 1/20 0.51
MAOA P21397 1/20 0.51
SLC6A2 P23975 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144484 0.81 JAK2 (0.80) JAK2DYRK1AALDH1A1KDM4EHPGD
SCHEMBL140533 0.81 JAK2 (1.00) JAK2DYRK1AALDH1A1HPGDACHE
SCHEMBL178818 0.79 JAK2 (0.65) JAK2DYRK1AALDH1A1KDM4EHPGD
SCHEMBL23150357 0.73 DYRK1A (1.00) DYRK1AALDH1A1KDM4EHPGDACHE
SCHEMBL9133082 0.73 JAK2 (0.54) JAK2ALDH1A1KDM4EHPGDCYP1A2
SCHEMBL16103012 0.72 DYRK1A (0.76) DYRK1AALDH1A1KDM4EHPGDACHE
SCHEMBL30939947 0.72 DYRK1A (0.76) DYRK1AALDH1A1KDM4EHPGDACHE
SCHEMBL142655 0.72 JAK2 (0.78) JAK2DYRK1AALDH1A1KDM4EHPGD
SCHEMBL16102894 0.71 DYRK1A (0.74) DYRK1AALDH1A1KDM4EHPGDACHE
SCHEMBL16123495 0.71 DYRK1A (0.74) DYRK1AALDH1A1KDM4EHPGDACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS JAK2, JAK1, JAK3 JAK2 1/4885DYRK1A 317/4885ALDH1A1 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.